Suppr超能文献

肥胖与代谢功能障碍相关脂肪性肝病青少年中的氧化型高密度脂蛋白和低密度脂蛋白

Oxidized high-density lipoprotein and low-density lipoprotein in adolescents with obesity and metabolic dysfunction-associated steatotic liver disease.

作者信息

Bartlett Alyssa M, Boone Ali M, Bays Jordan A, Kim Youngsil, Palle Sirish K, Short Kevin R

机构信息

Section of Diabetes and Endocrinology, Department of Pediatrics, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.

Section of Gastroenterology, Hepatology & Nutrition, Department of Pediatrics, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.

出版信息

Pediatr Obes. 2025 Feb;20(2):e13194. doi: 10.1111/ijpo.13194. Epub 2024 Dec 16.

Abstract

BACKGROUND

Metabolic dysfunction-associated steatotic liver disease (MASLD) is increasingly common in the pediatric population and may increase risk for developing cardiovascular disease (CVD) in people with MASLD. Oxidized high-density lipoprotein (oxHDL) and oxidized low-density lipoprotein (oxLDL) are modified, pro-atherosclerotic lipoproteins that are increased in adults with MASLD and CVD but have not been reported in adolescents with MASLD.

PURPOSE

To determine if oxLDL and oxHDL are increased in adolescents with MASLD.

METHODS

Fasting oxHDL and oxLDL were measured in adolescents (11-20 years) with obesity and biopsy-confirmed MASLD (n = 47), and peers without MASLD but with obesity (Ob; n = 28), or normal weight (NW; n = 29).

RESULTS

oxHDL was 27% higher (p < 0.05) in the MASLD group (mean ± SD: 11.9 ± 4.7 ng/mL) compared to the Ob group (9.3 ± 3.7 ng/mL, p < 0.05) but only 7% higher than the NW group (11.1 ± 3.8 ng/mL, p > 0.05). However, HDL-C was 19% and 32% lower in the MASLD group than in the Ob and NW groups, respectively. Thus, oxHDL/HDL-C ratio was 55% and 66% higher in MASLD compared to the Ob group (p < 0.004) and the NW group (p < 0.001), respectively. oxLDL (52.4 ± 16.0, 46.7 ± 10.1 and 47.1 ± 15.2 U/L for MASLD, Ob and NW, respectively), LDL-C and the oxLDL/LDL-C ratio did not differ among groups.

CONCLUSIONS

The elevated oxHDL and oxHDL/HDL-C in adolescents with MASLD compared to peers with Ob or NW suggests that there is some oxidative stress in MASLD independent of obesity and potential for increased CVD risk in the future.

摘要

背景

代谢功能障碍相关脂肪性肝病(MASLD)在儿科人群中日益常见,可能会增加MASLD患者患心血管疾病(CVD)的风险。氧化型高密度脂蛋白(oxHDL)和氧化型低密度脂蛋白(oxLDL)是经过修饰的促动脉粥样硬化脂蛋白,在患有MASLD和CVD的成年人中含量升高,但在患有MASLD的青少年中尚未见报道。

目的

确定患有MASLD的青少年的oxLDL和oxHDL是否升高。

方法

对患有肥胖症且经活检确诊为MASLD的青少年(11 - 20岁,n = 47)、无MASLD但患有肥胖症的同龄人(Ob;n = 28)或体重正常的同龄人(NW;n = 29)进行空腹oxHDL和oxLDL检测。

结果

与Ob组(9.3±3.7 ng/mL,p < 0.05)相比,MASLD组的oxHDL高27%(p < 0.05)(均值±标准差:11.9±4.7 ng/mL),但仅比NW组(11.1±3.8 ng/mL,p > 0.05)高7%。然而,MASLD组的高密度脂蛋白胆固醇(HDL-C)分别比Ob组和NW组低19%和32%。因此,MASLD组的oxHDL/HDL-C比值分别比Ob组(p < 0.004)和NW组(p < 0.001)高55%和66%。oxLDL(MASLD组、Ob组和NW组分别为52.4±16.0、46.7±10.1和47.1±15.2 U/L)、低密度脂蛋白胆固醇(LDL-C)以及oxLDL/LDL-C比值在各组之间无差异。

结论

与患有肥胖症或体重正常的同龄人相比,患有MASLD的青少年的oxHDL和oxHDL/HDL-C升高,这表明MASLD存在一些独立于肥胖的氧化应激,且未来患CVD的风险可能增加。

相似文献

2
Oxidized HDL and LDL in adolescents with type 2 diabetes compared to normal weight and obese peers.
J Diabetes Complications. 2015 Jul;29(5):679-85. doi: 10.1016/j.jdiacomp.2015.03.015. Epub 2015 Apr 6.
3
Serum adropin is unaltered in adolescents with histology-confirmed steatotic liver disease.
J Pediatr Gastroenterol Nutr. 2025 Jan;80(1):182-188. doi: 10.1002/jpn3.12423. Epub 2024 Nov 25.
6
Circulating oxidized LDL and inflammation in extreme pediatric obesity.
Obesity (Silver Spring). 2011 Jul;19(7):1415-9. doi: 10.1038/oby.2011.21. Epub 2011 Feb 17.
9
Positive correlation between n- 6 : n- 3 PUFA ratio intake with serum oxHDL/HDL-c ratio in patients with coronary artery disease.
Coron Artery Dis. 2025 May 1;36(3):190-199. doi: 10.1097/MCA.0000000000001437. Epub 2024 Oct 16.
10
Prevalence of Metabolic Dysfunction-associated Steatotic Liver Disease and Cardiometabolic Risk Factor in US Adolescents.
J Clin Endocrinol Metab. 2025 Apr 22;110(5):e1458-e1465. doi: 10.1210/clinem/dgae553.

本文引用的文献

1
NAFLD: An Emerging Causal Factor for Cardiovascular Disease.
Physiology (Bethesda). 2023 Nov 1;38(6):0. doi: 10.1152/physiol.00013.2023. Epub 2023 Jul 11.
2
PRO-C3, a Serological Marker of Fibrosis, During Childhood and Correlations With Fibrosis in Pediatric NAFLD.
Hepatol Commun. 2021 Nov;5(11):1860-1872. doi: 10.1002/hep4.1766. Epub 2021 Jul 8.
3
Pathological Crosstalk Between Oxidized LDL and ER Stress in Human Diseases: A Comprehensive Review.
Front Cell Dev Biol. 2021 May 26;9:674103. doi: 10.3389/fcell.2021.674103. eCollection 2021.
6
Progression of Fatty Liver Disease in Children Receiving Standard of Care Lifestyle Advice.
Gastroenterology. 2020 Nov;159(5):1731-1751.e10. doi: 10.1053/j.gastro.2020.07.034. Epub 2020 Jul 23.
8
Prevalence of Nonalcoholic Fatty Liver Disease in Children with Obesity.
J Pediatr. 2019 Apr;207:64-70. doi: 10.1016/j.jpeds.2018.11.021. Epub 2018 Dec 14.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验